[Rituximab in the treatment of diffuse large B-cell lymphoma: The CACNA1C subunit of channel Cav1.2 expression linked to certain forms of resistance].
Autor: | Bouabdallah S; M1 Biologie Santé, Université Paris-Saclay, 91405 Orsay, France., Mariko ML; M1 Biologie Santé, Université Paris-Saclay, 91405 Orsay, France., Besson J; M1 Biologie Santé, Université Paris-Saclay, 91405 Orsay, France., Dellis O; Inserm U1193 Physiopathologie et traitement des maladies du foie, Université Paris-Saclay, France. |
---|---|
Jazyk: | francouzština |
Zdroj: | Medecine sciences : M/S [Med Sci (Paris)] 2021 Apr; Vol. 37 (4), pp. 406-408. Date of Electronic Publication: 2021 Apr 28. |
DOI: | 10.1051/medsci/2021043 |
Databáze: | MEDLINE |
Externí odkaz: |